Yoko Otake
Impact in
- Biochemistry top 2%
- Phytochemicals and Antioxidant Activities
- Pharmacology top 1%
- Pharmacogenetics and Drug Metabolism
- Flavonoids in Medical Research
Papers in
-
- Pharmacogenetics and Drug Metabolism 4
- Flavonoids in Medical Research 2
-
- Phytochemicals and Antioxidant Activities 2
- Co-authors
- Thomas WalleU. Kristina WalleAlema GalijatovicPerry V. HalushkaFrederick A. WilsonDaniel FernandesEleanor K. SpicerTapas K. Sengupta
- Journals
- Drug Metabolism and Disposition (3 papers)Blood (2 papers)Xenobiotica (2 papers)Molecular Pharmacology (2 papers)Pharmaceutical Research (1 paper)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
Yoko Otake
18 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 94
- Biochemistry 287
- Pharmacology 265
- Pharmacology 196
- Molecular Biology 615
- Geriatrics and Gerontology 33
Countries citing papers authored by Yoko Otake
This map shows the geographic impact of Yoko Otake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoko Otake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoko Otake more than expected).
Fields of papers citing papers by Yoko Otake
This network shows the impact of papers produced by Yoko Otake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoko Otake. The network helps show where Yoko Otake may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoko Otake, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 2 | |
| 2 | 2007 | 8 | |
| 3 | The imidazoacridinone, C-1311 (Symadex™): The first of a potent new class of FLT3 inhibitors | 2006 | 4 |
| 4 | 2006 | 6 | |
| 5 | 2006 | 185 | |
| 6 | 2004 | 59 | |
| 7 | Drug-induced destabilization of bcl-2 mRNA: a new approach for inducing apoptosis in tumor cells. | 2004 | 13 |
| 8 | 2002 | 95 | |
| 9 | 2002 | 75 | |
| 10 | 2001 | 93 | |
| 11 | 2001 | 241 | |
| 12 | 2000 | 57 | |
| 13 | 2000 | 156 | |
| 14 | 2000 | 19 | |
| 15 | 2000 | 79 | |
| 16 | 1999 | 115 | |
| 17 | Establishment of a metastasizing human breast cancer cell line in nude mice. | 1980 | 2 |
| 18 | 1965 | 1 |
About Yoko Otake
Yoko Otake is a scholar working on Pharmacology, Biochemistry, Molecular Medicine, Molecular Biology and Complementary and alternative medicine, having authored 18 papers that have together received 1.2k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Drug Transport and Resistance Mechanisms (2 papers), RNA Interference and Gene Delivery (2 papers), Phytochemistry and Biological Activities (2 papers), Cancer therapeutics and mechanisms (2 papers), DNA and Nucleic Acid Chemistry (2 papers), Phytochemicals and Antioxidant Activities (2 papers) and Flavonoids in Medical Research (2 papers). The work is most often cited by research in Biochemistry (287 citations), Pharmacology (265 citations), Pharmacology (196 citations), Molecular Biology (615 citations) and Geriatrics and Gerontology (33 citations). Yoko Otake has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include Thomas Walle, U. Kristina Walle, Alema Galijatovic, Perry V. Halushka, Frederick A. Wilson, Daniel Fernandes, Eleanor K. Spicer, Tapas K. Sengupta, Faye Hsieh and Robert K. Stuart. Their work appears in journals such as Drug Metabolism and Disposition, Blood, Xenobiotica, Molecular Pharmacology and Pharmaceutical Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.